Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aurobindo Pharma has obtained the US Food and Drug Administration's (FDA) final approval for Venlafaxine Hydrochloride Extended-release capsules 37.5mg, 75mg and 150mg, as a treatment for major depressive disorder (MDD).
Subscribe to our email newsletter
Venlafaxine Hydrochloride Extended-release capsules 37.5mg, 75mg and 150mg are generic equivalent of Wyeth Pharmaceuticals’ Effexor XR capsules 37.5mg, 75mg and 150mg.
Aurobindo Pharma received tentative approval from the FDA to manufacture and market Hydrochloride Extended-release capsules 37.5mg, 75mg and 150mg on 24 February 2011.
The company intends to introduce the product after 1 June 2011, Pharmabiz reported.